Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.

Simulations Plus faces weak biopharma demand, slowing growth, margin pressure, and high valuation amid M&A reliance. See why ...

Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...

The drug, used to treat parasitic worms, has not been formulated or labeled specifically for over-the-counter use, like ...

A former FDA reviewer offers advice to help innovative medtech avoid new and more dangerous pitfalls as experts leave the ...

President Trump’s former surgeon general blasted Health and Human Services Secretary Robert F. Kennedy’s Jr.’s decision to fire the entirety of a federal advisory committee ...

NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in therapeutic devices, announced today, through its ENvue Medical Holdings LLC division ...

ASX health stocks rise in week ending June 13, 2025 as Cochlear downgrades full-year profit expectations but launches a world ...

The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and biologics by publishing its first provisional guidance on the technology's ...

Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...